Z-1107-2021 Class II Terminated
FDA device recall Z-1107-2021 was initiated by Phadia US Inc on Dec 14, 2020 and is designated Class II. Reason for recall: Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results). The recall status is terminated (terminated Aug 4, 2022). Affected quantity: 365 kits US.
Recall details
- Product Type
- Devices
- Report Date
- Feb 17, 2021
- Initiation Date
- Dec 14, 2020
- Termination Date
- Aug 4, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 365 kits US
Product description
EliA dsDNA Well - Product Usage: intended for the In-Vitro quantitative measurement of IgG antibodies directed to dsDNA in human serum and plasma as an aid in the clinical diagnosis of systemic lupus erythematosus (SLE). Material Number: 14-5500-01
Reason for recall
Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results).
Distribution pattern
US Nationwide distribution.
Code information
Carrier Lot Number: BFA3Y; Kit Lot Number: 0142; (UDI): 07333066019406
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1107-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026